CR20160184A - Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasa - Google Patents
Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasaInfo
- Publication number
- CR20160184A CR20160184A CR20160184A CR20160184A CR20160184A CR 20160184 A CR20160184 A CR 20160184A CR 20160184 A CR20160184 A CR 20160184A CR 20160184 A CR20160184 A CR 20160184A CR 20160184 A CR20160184 A CR 20160184A
- Authority
- CR
- Costa Rica
- Prior art keywords
- transferasa
- piperidil
- etil
- acil
- ghrelin
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000012004 Ghrelin Human genes 0.000 title 1
- 101800001586 Ghrelin Proteins 0.000 title 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 title 1
- 241000283707 Capra Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a inhibidores de GOAT novedosos y sus sales y composiciones farmacéuticas de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382460 | 2013-11-14 | ||
| PCT/US2014/064202 WO2015073281A1 (en) | 2013-11-14 | 2014-11-06 | Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20160184A true CR20160184A (es) | 2016-06-17 |
Family
ID=49622771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20160184A CR20160184A (es) | 2013-11-14 | 2016-04-21 | Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasa |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US9035051B1 (es) |
| EP (1) | EP3068775B1 (es) |
| JP (1) | JP6159484B2 (es) |
| KR (1) | KR101739243B1 (es) |
| CN (1) | CN105636948B (es) |
| AP (1) | AP2016009189A0 (es) |
| AR (1) | AR098274A1 (es) |
| AU (1) | AU2014348967B2 (es) |
| BR (1) | BR112016009488B1 (es) |
| CA (1) | CA2926224C (es) |
| CL (1) | CL2016001023A1 (es) |
| CR (1) | CR20160184A (es) |
| CY (1) | CY1119489T1 (es) |
| DK (1) | DK3068775T3 (es) |
| DO (1) | DOP2016000070A (es) |
| EA (1) | EA028550B1 (es) |
| ES (1) | ES2647790T3 (es) |
| HR (1) | HRP20171648T1 (es) |
| HU (1) | HUE035590T2 (es) |
| IL (1) | IL244856A (es) |
| JO (1) | JO3302B1 (es) |
| LT (1) | LT3068775T (es) |
| MA (1) | MA39025B1 (es) |
| ME (1) | ME02841B (es) |
| MX (1) | MX2016006223A (es) |
| NO (1) | NO3068775T3 (es) |
| NZ (1) | NZ718373A (es) |
| PE (1) | PE20160609A1 (es) |
| PH (1) | PH12016500895A1 (es) |
| PL (1) | PL3068775T3 (es) |
| PT (1) | PT3068775T (es) |
| RS (1) | RS56533B1 (es) |
| SG (1) | SG11201602953YA (es) |
| SI (1) | SI3068775T1 (es) |
| TN (1) | TN2016000145A1 (es) |
| TW (1) | TWI538677B (es) |
| UA (1) | UA118034C2 (es) |
| WO (1) | WO2015073281A1 (es) |
| ZA (1) | ZA201602202B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR104672A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| AR104673A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| JP6651054B2 (ja) * | 2016-08-05 | 2020-02-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グレリンｏ−アシルトランスフェラーゼ（ｇｏａｔ）阻害薬として使用するためのオキサジアゾロピリジン誘導体 |
| CN106478519B (zh) * | 2016-10-10 | 2018-12-11 | 上海再启生物技术有限公司 | 一种2-甲基-4-氨基-6-氯嘧啶的制备方法 |
| WO2019149658A1 (en) | 2018-02-02 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
| CA3087826A1 (en) * | 2018-02-02 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin o-acyl transferase (goat) inhibitors |
| CR20200331A (es) * | 2018-02-02 | 2020-09-03 | Boehringer Ingelheim Int | Derivados de oxadiazolopirisdina sustituidos con heterociclilo para usar como inhibidores de ghrelin o-aciltrasferasa (goat) |
| JP7083397B2 (ja) | 2018-02-02 | 2022-06-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グレリンｏ－アシルトランスフェラーゼ（ｇｏａｔ）阻害剤として使用するためのトリアゾロピリミジン誘導体 |
| CN108516971A (zh) * | 2018-05-30 | 2018-09-11 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108558849A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108558852A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108774221A (zh) * | 2018-05-30 | 2018-11-09 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108610337A (zh) * | 2018-05-30 | 2018-10-02 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| PH12022552277A1 (en) | 2020-02-28 | 2024-03-04 | Kallyope Inc | Gpr40 agonists |
| PL4153600T3 (pl) | 2020-05-22 | 2024-12-16 | Boehringer Ingelheim International Gmbh | Sposób ciągły wytwarzania 7-amino-5-metylo-[1,2,5]oksadiazolo[3,4- b]pirydynokarboksylanu alkilu |
| WO2021233882A1 (en) | 2020-05-22 | 2021-11-25 | Boehringer Ingelheim International Gmbh | Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003528088A (ja) * | 2000-03-23 | 2003-09-24 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体作働薬としての置換ピペリジン類 |
| WO2005026211A2 (en) | 2003-09-05 | 2005-03-24 | Eli Lilly And Company | Anti-ghrelin antibodies |
| EP1776386A1 (en) | 2004-07-14 | 2007-04-25 | Eli Lilly And Company | Anti-ghrelin antibodies |
| CA2587627A1 (en) | 2004-11-15 | 2006-05-26 | Eli Lilly And Company | Desacyl ghrelin antibodies and therapeutic uses thereof |
| EP1856154A1 (en) | 2005-02-23 | 2007-11-21 | Eli Lilly And Company | Humanized anti-ghrelin antibodies |
| JP4975739B2 (ja) * | 2005-05-17 | 2012-07-11 | シェーリング コーポレイション | 脂質異常症の処置のための、ニコチン酸受容体アゴニストとしての複素環 |
| CN101175759A (zh) * | 2005-05-17 | 2008-05-07 | 先灵公司 | 作为治疗血脂异常的烟酸受体激动剂的杂环化合物 |
| US20070213359A1 (en) * | 2005-12-30 | 2007-09-13 | Acadia Pharmaceuticals Inc. | Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| MX2010010241A (es) * | 2008-03-20 | 2010-12-06 | Forest Lab Holdings Ltd | Derivados de piperidina novedosos como inhibidores de estearoil-coa desaturasa. |
| AR091516A1 (es) * | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida |
-
2014
- 2014-06-11 UA UAA201604765A patent/UA118034C2/uk unknown
- 2014-10-30 JO JOP/2014/0316A patent/JO3302B1/ar active
- 2014-10-31 TW TW103137938A patent/TWI538677B/zh active
- 2014-11-03 AR ARP140104111A patent/AR098274A1/es unknown
- 2014-11-06 MA MA39025A patent/MA39025B1/fr unknown
- 2014-11-06 ES ES14802755.0T patent/ES2647790T3/es active Active
- 2014-11-06 PL PL14802755T patent/PL3068775T3/pl unknown
- 2014-11-06 WO PCT/US2014/064202 patent/WO2015073281A1/en not_active Ceased
- 2014-11-06 ME MEP-2017-224A patent/ME02841B/me unknown
- 2014-11-06 TN TN2016000145A patent/TN2016000145A1/en unknown
- 2014-11-06 PT PT148027550T patent/PT3068775T/pt unknown
- 2014-11-06 LT LTEP14802755.0T patent/LT3068775T/lt unknown
- 2014-11-06 EA EA201690764A patent/EA028550B1/ru not_active IP Right Cessation
- 2014-11-06 CA CA2926224A patent/CA2926224C/en active Active
- 2014-11-06 US US14/534,212 patent/US9035051B1/en active Active
- 2014-11-06 BR BR112016009488-3A patent/BR112016009488B1/pt active IP Right Grant
- 2014-11-06 KR KR1020167012340A patent/KR101739243B1/ko active Active
- 2014-11-06 HR HRP20171648TT patent/HRP20171648T1/hr unknown
- 2014-11-06 EP EP14802755.0A patent/EP3068775B1/en active Active
- 2014-11-06 CN CN201480058584.6A patent/CN105636948B/zh active Active
- 2014-11-06 RS RS20171067A patent/RS56533B1/sr unknown
- 2014-11-06 HU HUE14802755A patent/HUE035590T2/en unknown
- 2014-11-06 SI SI201430379T patent/SI3068775T1/sl unknown
- 2014-11-06 NO NO14802755A patent/NO3068775T3/no unknown
- 2014-11-06 AP AP2016009189A patent/AP2016009189A0/en unknown
- 2014-11-06 MX MX2016006223A patent/MX2016006223A/es active IP Right Grant
- 2014-11-06 PE PE2016000620A patent/PE20160609A1/es active IP Right Grant
- 2014-11-06 JP JP2016531705A patent/JP6159484B2/ja active Active
- 2014-11-06 AU AU2014348967A patent/AU2014348967B2/en active Active
- 2014-11-06 SG SG11201602953YA patent/SG11201602953YA/en unknown
- 2014-11-06 DK DK14802755.0T patent/DK3068775T3/en active
- 2014-11-06 NZ NZ718373A patent/NZ718373A/en unknown
-
2016
- 2016-03-29 DO DO2016000070A patent/DOP2016000070A/es unknown
- 2016-04-03 IL IL244856A patent/IL244856A/en active IP Right Grant
- 2016-04-04 ZA ZA201602202A patent/ZA201602202B/en unknown
- 2016-04-21 CR CR20160184A patent/CR20160184A/es unknown
- 2016-04-29 CL CL2016001023A patent/CL2016001023A1/es unknown
- 2016-05-13 PH PH12016500895A patent/PH12016500895A1/en unknown
-
2017
- 2017-10-20 CY CY20171101093T patent/CY1119489T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20160184A (es) | Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasa | |
| UY4175Q (es) | Reloj pulsera | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| ES2530968T3 (es) | Pirrolobenzodiazepinas y conjugados de las mismas | |
| CR20140464A (es) | Compuestos de heterociclilo | |
| CR20150507A (es) | Inhibidores de histona desmetilasas | |
| GEAP201814347A (en) | Substituted dihydroisoquinoline compounds | |
| CR20140106A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
| HUE045725T2 (hu) | Ciklopropilaminok mint LSD1 inhibitorok | |
| CR20150061A (es) | Compuesto de pirazolopirimidinas | |
| HUE043440T2 (hu) | Policiklusos amidszármazékok mint CDK9 inhibitorok | |
| LT2895484T (lt) | Gliukozilceramido sintazės inhibitoriai | |
| ME03336B (me) | Inhibitori dnk-pk | |
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| BR112017005266A2 (pt) | inibidores de mk2 e uso dos mesmos | |
| CO7111315A2 (es) | Dihidrato de un compuesto de benzotiofeno o de una de sus sales y proceso para su producción | |
| CO7091177A2 (es) | Inhibidores de la beta-secretasa | |
| EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
| BR112015003294A2 (pt) | caldeira de armazenamento | |
| UY34666A (es) | Inhibidores de quinasa a base de ariléter | |
| MX2017007377A (es) | Compuestos organicos. | |
| DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
| ECSP14013305A (es) | Moduladores selectivos del receptor andrógeno | |
| UY34631A (es) | Formulación de doxilamina y piridoxina y/o sus metabolitos o sales | |
| CR20180089A (es) | Compuestos útiles para inhibir a ror-gamma-t |